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 33 
Summary 34 
 35 
Long-range axonal retrograde transport is a key mechanism for the cellular dissemination 36 
of neuro-invasive viruses, such as Borna Disease Virus (BDV), for which entry and egress 37 
sites are usually distant from the nucleus, where viral replication takes place. Although BDV 38 
is known to disseminate very efficiently in neurons, both in vivo and in primary cultures, the 39 
modalities of its axonal transport are still poorly characterized. In this work, we combined 40 
different methodological approaches, such as confocal microscopy and biochemical 41 
purification of endosomes, to study BDV retrograde transport. We demonstrate that BDV 42 
ribonucleoparticles (composed of the viral genomic RNA, nucleoprotein and phosphoprotein), 43 
as well as the matrix protein, are transported towards the nucleus into endocytic carriers. 44 
These specialized organelles, called signaling endosomes, are notably used for the retrograde 45 
transport of neurotrophins and activated growth factor receptors. Signaling endosomes have a 46 
neutral luminal pH and thereby offer protection against degradation during long-range 47 
transport. This particularity could allow the viral particles to be delivered intact to the cell 48 
body of neurons, avoiding their premature release in the cytoplasm. 49 
  50 
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Introduction 51 
 52 
 Borna Disease Virus (BDV) is a non-segmented, negative-stranded RNA virus 53 
belonging to the Bornaviridae family. Its 8.9 kb genome, the smallest of the Mononegavirales 54 
order, encodes only six proteins (de la Torre, 1994): the nucleoprotein (N), the viral 55 
polymerase (L) and its cofactor the phosphoprotein (P), the matrix protein (M), the 56 
glycoprotein (G) and the non-structural small protein X. The enveloped virion contains the 57 
ribonucleoparticle (RNP), composed of the viral genomic RNA encapsidated into BDV N, in 58 
interaction with BDV L, P and M proteins. The envelope is composed of a membrane in 59 
which are found the two isoforms of BDV G (84 and 43 kDa) (Gonzalez-Dunia et al., 1998). 60 
 In vivo, BDV preferentially targets neurons of the central nervous system (CNS), 61 
although it can infect a large variety of cell types in vitro (de la Torre, 2002, Gonzalez-Dunia 62 
et al., 2005). It has the particularity, unique among Mononegavirales, to replicate in the 63 
nucleus of infected cells without developing any cytopathic effect. Despite numerous studies, 64 
some steps of its replication cycle remain, however, unknown. In particular, receptor-65 
mediated entry, retrograde transport to the nucleus, virion assembly and release are not well 66 
characterized (Lipkin et al., 2011). Following interaction with a still unknown receptor, BDV 67 
enters the cell via clathrin-dependent endocytosis to form a vesicle that fuses with an early 68 
endosome. Then, acidification of the late endosome allows the fusion between viral and 69 
endosomal membranes and RNP release (Clemente et al., 2009). After genome replication 70 
and protein synthesis, the precise modalities of virion assembly are still unknown. In 71 
particular, whether RNPs follow an anterograde transport route in an enveloped form or naked 72 
is not known, and even if neuron-to-neuron transmission occurs with enveloped virions and/or 73 
with non-enveloped RNPs (Clemente et al., 2007). Previous work from our team allowed the 74 
observation of BDV RNP trafficking in non-neuronal cells by the use of a recombinant 75 
fluorescent-tagged virus (Charlier et al., 2013). In neurons, however, one important feature of 76 
the BDV replication cycle is the necessity of a long-range retrograde and anterograde 77 
transport via the axonal route, since entry and egress sites are often distant from the cell body, 78 
where viral replication takes place. 79 
 Axonal transport is a key mechanism for neuroinvasive pathogens (Taylor et al., 2015). 80 
Indeed, the long distances separating somas from nerve terminals imply that neurotropic 81 
viruses must use specialized molecular motors to move in a vectorial manner along axons and 82 
cannot solely rely on passive diffusion. Two principal strategies for axonal retrograde 83 
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transport are described for pathogens (Salinas et al., 2010). The first one is to directly recruit 84 
molecular motors, such as cytoplasmic dynein or its associated complex dynactin, as 85 
exemplified by Herpes Simplex Virus type 1 (HSV-1). After membrane fusion, HSV-1 naked 86 
particle is released into the cytoplasm. Several proteins of the tegument then recruit dynein, 87 
dynactin, and adaptor proteins, allowing a rapid retrograde transport along microtubules 88 
(Diefenbach et al., 2008). Another strategy for axonal trafficking is to use vesicular transport. 89 
Indeed, membrane organelles, such as endocytic and exocytic vesicles, constantly travel along 90 
axons and several pathogens access these organelles to spread in the CNS. This is for example 91 
the case for Canine Adenovirus type 2 (CAV-2), which enters the cell by receptor-mediated 92 
endocytosis before traveling into axonal endosomes (Salinas et al., 2009). Another well 93 
documented example is tetanus neurotoxin (TeNT), which also uses the vesicular pathway to 94 
be transported in neurons (Lalli et al., 2003). These endocytic structures, also called signaling 95 
endosomes, are usually responsible for the transport of neurotrophins, such as nerve growth 96 
factor or brain-derived neurotrophic factor (BDNF), as well as of their corresponding 97 
receptors p75NTR and TrkB (Bucci et al., 2014). An important characteristic of these vesicles 98 
is that their luminal pH is close to neutral (Bohnert et al., 2005). This allows cargoes to be 99 
transported over long distances in a protective environment, avoiding pH-dependent 100 
conformational changes. Neutral axonal endosomes could therefore constitute an ideal 101 
transport pathway for neurotropic viruses to reach the cell body without destabilization of the 102 
viral particle, preventing membrane fusion and premature release of the viral genome (Salinas 103 
et al., 2010). 104 
 Although BDV is known to disseminate particularly well in neurons, both in vivo in 105 
the CNS and in vitro in neuronal primary cultures or in organotypic hippocampal slices 106 
(Bajramovic et al., 2003, Daito et al., 2011a, Wu et al., 2013), the modalities of its axonal 107 
transport are still poorly characterized. So far, no study has described any direct interaction 108 
between a component of the BDV particle and a molecular motor. Moreover, BDV entry 109 
follows a receptor-dependent endocytosis pathway that requires the small GTPase Rab5 110 
(Clemente et al., 2009), a protein also implicated in the transport of axonal endosomes 111 
(Deinhardt et al., 2006). These data argue for the hypothesis that BDV particles could be 112 
transported into signaling endosomes. In this work, we combined different methodological 113 
approaches, based on colocalization studies and biochemical purification of endosomes, to 114 
determine whether BDV uses such vesicular pathway for its retrograde axonal transport. 115 
 116 
 117 
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Results 118 
 119 
BDV particles and TeNT colocalize in axonal vesicles. In a first attempt to investigate 120 
whether BDV particles are transported along axonal endosomes, we sought to perform 121 
colocalization studies between BDV and known axonal cargoes. Among well-described 122 
axonal cargoes, TeNT undergoes specific uptake and retrograde transport in axonal 123 
endosomes (Lalli et al., 2002). Here, we used the binding fragment of tetanus neurotoxin 124 
(HCT), coupled to Alexa Fluor 555 (HCT-555), which is as a very reliable tool to monitor 125 
axonal retrograde transport of signaling endosomes (Lalli et al., 1999, Lalli et al., 2002, 126 
Debaisieux et al., 2016). Therefore, we performed colocalization studies between HCT-555 127 
and BDV particles in fixed neurons. 128 
 To this aim, we used primary cultures of hippocampal neurons, which present long 129 
axons allowing easy detection of BDV particles. By performing preliminary kinetic analyses 130 
of infection, we determined that a punctate staining, likely corresponding to BDV particles, 131 
was best detected in axons eight to ten days after virus inoculation (data not shown). We thus 132 
labeled neurons with HCT-555 at ten days post-infection before proceeding to colocalization 133 
studies. We performed indirect immunofluorescence experiments against BDV N or P 134 
proteins, the two main components of BDV RNPs, and colocalization analyses with HCT-555 135 
were performed by confocal microscopy (Fig. 1A and 1B, upper panels). In parallel, neurons 136 
were stained for β−III tubulin, to verify the axonal integrity (data not shown). Each 137 
colocalization event was confirmed by drawing an intensity profile (Fig. 1A and 1B, lower 138 
panels). To determine the colocalization percentages between BDV N or P and HCT-555, we 139 
analyzed all the vesicles containing BDV N or P proteins. Among them, we determined the 140 
proportion which was also positive for HCT-555 (Fig. 1C). We observed that around 75% of 141 
BDV N-containing vesicles and 65% of BDV P-containing vesicles were also positive for 142 
HCT-555. These first results argue for a transport of BDV in axonal endosomes in cultured 143 
hippocampal neurons. 144 
  145 
Biochemical approaches to purify axonal endosomes. We next decided to complete these 146 
results by a biochemical approach based on the purification of axonal endosomes and the 147 
analysis of their protein content (Fig. 2). Primary cultures of cortical neurons were infected by 148 
BDV, or left non-infected as a control, and maintained for 13 days, a time necessary to allow 149 
BDV spreading to the entire culture, as demonstrated in previous studies (Bajramovic et al., 150 
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2003). They were then submitted to either whole cell lysis, or gentle cell lysis to preserve 151 
cellular organelles, notably axonal endosomes (see Fig. 2 and Experimental Procedures). We 152 
next used two complementary methods to obtain axonal endosome-enriched fractions (Fig. 2). 153 
The first one consisted in performing immunoprecipitation against Trk receptors, which are 154 
markers for axonal endosomes (Method 1) (Bucci et al., 2014). The second one consisted of 155 
flow cytometry-based sorting of axonal endosomes labelled by fluorescent HCT that was 156 
beforehand pre-incubated with neurons (Method 2). 157 
 158 
Axonal endosomes obtained by immunoprecipitation contain BDV proteins. We first 159 
sought to purify axonal endosomes by performing immunoprecipitation experiments using a 160 
pan-Trk antibody. This antibody recognizes the cytoplasmic portion of Trk receptors, the 161 
cellular receptors of several neurotrophins, including BDNF, which localize in axonal 162 
endosomes (Lalli et al., 2002). The protein content of the immunoprecipitates was then 163 
analyzed by western blotting (Fig. 3).  164 
  We first carried out control experiments in which we performed a whole cell lysis 165 
of non-infected or infected neurons, leading to the disruption of all cellular organelles, 166 
including axonal endosomes (Fig. 3). As expected, we observed the presence of TrkB in the 167 
immunoprecipitates (Figure 3A). Another endosomal marker, Rab7 (Chavrier et al., 1990), 168 
which does not interact with Trk receptors, was also detected in the input fractions, but not in 169 
the immunoprecipitates, confirming that axonal endosomes had indeed been disrupted during 170 
cell lysis. Moreover, BDV N, P, G and M proteins were not found in the immunoprecipitate 171 
obtained from infected neurons, indicating that they do not directly interact with Trk receptors 172 
(Fig. 3A). 173 
 We repeated the same anti pan-Trk immunoprecipitation experiment after having 174 
performed a gentle cell lysis to preserve axonal endosomes (Fig. 3B). In this case, Rab7 was 175 
found associated to the Trk immunoprecipitates, in contrast to what was observed with whole 176 
cell lysis, indicating that this method allows the preservation of axonal endosome integrity. 177 
Moreover, BDV N, P, G and M were also found in the immunoprecipitates obtained from 178 
infected neurons, indicating that BDV proteins are present in the axonal endosome-enriched 179 
fraction.  180 
 However, we reasoned that this purification method based on the isolation of Trk-181 
containing endosomes might not be optimal. Indeed, Trk receptors follow the classical 182 
secretory pathway. As such they transit through the endoplasmic reticulum (ER) and Golgi 183 
apparatus after synthesis before reaching the plasma membrane. As a matter of fact, western 184 
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 7 
blot experiments revealed that markers such as GM-130 (Golgi Matrix protein of 130 kDa), 185 
ERGIC (ER Golgi Intermediate Compartment) and calnexin (ER) (Schweizer et al., 1988, 186 
Wada et al., 1991, Marra et al., 2001) were also present in our immunoprecipitates (Fig. 3C), 187 
suggesting that the immunoprecipitates of Trk-containing axonal endosomes may also contain 188 
other subcellular organelles. 189 
 190 
Flow cytometry-sorted axonal endosomes contain BDV proteins and the viral genome. 191 
We thus decided to develop an alternative approach to purify axonal endosomes with greater 192 
efficiency. To this aim, we developed a biochemical approach based on flow cytometry 193 
sorting of fluorescently-labeled endosomes. Similar to our colocalization studies (see Fig. 1), 194 
we used HCT as an endosomal probe, which was labeled with Alexa Fluor 647 dye for its 195 
detection by flow cytometry (HCT-647). 196 
 Considering the expected size of axonal endosomes (between 100 and 1 µm), we 197 
first calibrated our flow cytometer for the detection of small particles. Latex particles of 198 
distinct known sizes (0.1, 0.5, 1 and 3 µm) were used to set up the flow cytometer FSC and 199 
SCC parameters. We next observed that we could also detect and discriminate fluorescent 200 
standard microbeads of 0.5, 0.9 and 3 µm (data not shown). Next, we analyzed cell 201 
homogenates obtained by gentle cell lysis of non-infected neurons that had been previously 202 
incubated with HCT-647. Flow cytometry analysis of the crude cell homogenates revealed a 203 
population of events with a relatively continuous size and granulometry distribution (Fig. 4A, 204 
left panel). These events were size-gated into three populations, designated as P1 to P3, that 205 
were then analyzed for fluorescence intensity and count number (Fig. 4A). Alexa 647-positive 206 
events were then gated and sorted to obtain F1 and F2 fractions. As expected, no fluorescent 207 
events were detected in a control experiment using neurons that had not been exposed to HCT-208 
647 (Fig. 4B). 209 
 We next analyzed the protein content of the sorted endosome-containing fractions 210 
obtained from non-infected or infected neurons. We focused on the F1 fraction, because it 211 
mostly contains fluorescent events (>86%). Moreover, the paucity of the material present in 212 
F2 fractions (680 fluorescent positive events sorted in F2 fraction vs. 2,880 in F1 fraction) 213 
limited the protein content available for western blotting experiments. In F1 fractions sorted 214 
from non-infected neurons, western blot analysis revealed the presence of the axonal 215 
endosome markers TrkB and Rab7, suggesting that this method allowed the purification of 216 
preserved axonal endosomes (Fig. 5A, left panel). When a similar analysis was performed 217 
using infected neurons, we also detected the presence of BDV N, P and M proteins in addition 218 
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to TrkB and Rab7 (Fig. 5A, right panels). We, however, did not succeed in detecting BDV G 219 
isoforms, probably due to the limiting amounts of protein content, together with the fact that 220 
anti-BDV G antibody is not as sensitive as the other anti-BDV antibodies used in this study 221 
(data not shown). Moreover, in contrast to the results obtained with the immuno-purification 222 
of Trk-containing endosomes, western blot analysis of F1-sorted fractions revealed that they 223 
were negative for GM-130, calnexin or ERGIC antigens (Fig. 5B), suggesting that such a 224 
flow cytometry-based sorting allows a more stringent purification of axonal endosomes.  225 
 Lastly, we investigated whether BDV genomic RNA was also found in F1-sorted 226 
fractions. We purified total RNAs from F1 fractions and performed a reverse-transcription 227 
experiment targeting the viral (negative sense) genomic RNA. The resulting cDNAs were 228 
then amplified by PCR, using BDV-specific primers. As shown in Fig. 5C, a DNA fragment 229 
at the expected size of 360 bp was amplified specifically in F1 fractions obtained from 230 
infected neurons, demonstrating that the viral genomic RNA is present in axonal endosomes, 231 
in addition to the above-mentioned BDV proteins.  232 
 233 
Discussion 234 
 One requirement for neurotropic viruses to disseminate efficiently into the CNS is that 235 
viral proteins, genome and/or particle must move over long distances along axons, a highly 236 
specialized neuronal compartment. Although the strong neuroinvasive properties of BDV 237 
have been observed long ago, either in animal models or using in vitro systems (Bajramovic 238 
et al., 2003, Daito et al., 2011a, Wu et al., 2013), the strategy adopted by this virus upon 239 
infection to reach the neuronal nucleus, where viral replication takes place, still remains a 240 
mystery. In this study, we sought to gain further insights into the modalities of BDV axonal 241 
transport.  242 
Colocalization studies performed by confocal microscopy on hippocampal axons 243 
indicated that approximately 70% of BDV antigen-containing puncta were also positive for 244 
HCT, a probe specific for axonal endosomes (Lalli et al., 2003, Salinas et al., 2010 ). This 245 
result is comparable to what has been observed with CAV-2, another virus described to travel 246 
in signaling endosomes in motor neurons (Salinas et al., 2009), and therefore constitutes a 247 
strong argument in favor of BDV being recruited to axonal transport carriers. The remaining 248 
30% of BDV antigen-containing puncta that are negative for HCT could have stochastically 249 
internalized BDV and not HCT. It is also possible that part of this staining corresponds to 250 
vesicles containing newly synthesized BDV virions (or RNPs) that are traveling in an 251 
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anterograde direction and thus do not contain HCT. Indeed, even if a punctate axonal staining 252 
for BDV antigens is usually observed at early stages after infection, we cannot exclude the 253 
possibility that neo-synthetized virions may also be present in neurons, since our 254 
immunofluorescence analyses have been performed ten days post-infection, a time sufficient 255 
to allow production of new viral progeny. Indeed, given the paucity of cell-free virus 256 
produced by BDV-infected cells, it is unfortunately not possible to use a stronger multiplicity 257 
of infection and visualize viral spread at earlier time points. 258 
 We next decided to perform biochemical purification of Trk-containing endosomes, 259 
taking advantage of an experimental strategy used by several groups for the study of signaling 260 
endosomes (Mitchell et al., 2012 , Zhou et al., 2012). By this method, we were able to detect 261 
axonal endosome markers, such as TrkB and Rab7 in the immunoprecipitates, validating this 262 
experimental approach. Moreover, BDV N, P, M and G proteins were also found in the 263 
immunoprecipitates. However, a key feature of axonal transport is that cellular proteins that 264 
will ultimately be transported in a retrograde manner, such as Trk receptors themselves, must 265 
first be delivered to the axon terminus. Consequently, Trk receptors first follow the classical 266 
cellular secretory pathway, transiting via ER and Golgi apparatus and reach the axon terminus 267 
by anterograde transport (Ascano et al., 2009). Thus, immunoprecipitation of Trk-containing 268 
endosomes not only purifies endosomes that move in the retrograde direction but also vesicles 269 
that are delivered to the axon plasma membrane, as well as ER- and Golgi-derived 270 
microsomes. Control western blot experiments indeed showed that ER and Golgi proteins 271 
were present in pan-Trk immunoprecipitates. In any event, as BDV N, P and M are directly 272 
translated into the cell cytoplasm and not on ER-associated ribosomes, our results clearly 273 
demonstrate that these proteins are found in axonal endosomes. For BDV G, however, results 274 
need to be interpreted with caution. Indeed, BDV G follows the cellular secretory pathway 275 
and both the entire protein and its two cleaved isoforms associate with ER and Golgi (Daito et 276 
al., 2011b). We therefore cannot rule out the possibility that part of BDV G may actually be 277 
immunoprecipitated from ER- and Golgi-derived microsomes. 278 
Flow cytometry-based sorting of HCT-containing vesicles allowed to definitively 279 
conclude that BDV components were actually transported by axonal endosomes. Clearly, HCT 280 
represents a more stringent marker of axonal endosomes than Trk receptors, since it only 281 
follows retrograde transport and does not transit through the ER or Golgi (Lalli et al., 2003, 282 
Salinas et al., 2010 ). As a matter of fact, no trace of ER or Golgi apparatus markers were 283 
found in the sorted fractions, confirming the reliability of HCT as an axonal endosome probe. 284 
This also demonstrates that the use of a cell cracker is indeed appropriate to obtain intact 285 
Page 9 of 23 Cellular Microbiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 10 
endosomes, since it has been suggested that the mechanical forces applied for cell 286 
fractionation might create hybrid membrane vesicles (Salomon et al., 2010).  287 
Since BDV N, P and M proteins, as well as the viral genome, were all detected in sorted 288 
HCT positive fractions, it is very likely that BDV RNPs are actually present in axonal 289 
endosomes. We, however, were unable to detect BDV G by western blot. We thus cannot 290 
conclude whether BDV particles are transported along axonal endosomes in an enveloped or 291 
uncoated form. In neuronal primary cultures, BDV spreads without any detectable 292 
extracellular virus or syncytium formation (Bajramovic et al., 2003) and the precise 293 
contribution of BDV G in neuronal spread remains debated (Clemente et al., 2007). One 294 
current hypothesis proposes two modes of virus propagation into neurons: a primary infection 295 
that depends on the binding of BDV G to its receptor, followed by a cell-to-cell viral spread 296 
that would not necessarily require the BDV G protein (Lennartz et al., 2016).  297 
Another common pathway between HCT and BDV is the initial association with Rab5-298 
positive early endosomes. This is particularly interesting when considering that there are clear 299 
functional differences between axonal endosomes and endocytic organelles found in epithelial 300 
cells. Notably, in contrast to epithelial cells, Rab7-positive axonal endosomes display a 301 
neutral luminal pH (Bohnert et al., 2005, Salinas et al., 2009). By transiting through such 302 
non-acidic axonal endosomes, BDV particles could remain efficiently associated with long-303 
range transport vesicles until being delivered to the soma, triggering the exit of the viral 304 
material from these compartments. As such, neutral axonal endosomes may offer an efficient 305 
protection against degradation during long-range transport, allowing the viral particle to be 306 
delivered intact to the cell body of neurons. This might also explain why BDV disseminates 307 
much better in primary neuronal cultures when compared to other cell types. In non-neuronal 308 
cell types, the cell-to-cell spread of BDV is relatively inefficient, as attested by the paucity of 309 
BDV fluorescent particles routing to the nucleus detected in our recent study, which had been 310 
performed in epithelial Vero cells (Charlier et al., 2013). This may actually be explained by 311 
the fact that BDV particles would be prematurely released into the cytoplasm, due to the early 312 
acidification of endosomes. 313 
Recently, a proteomic analysis of the composition of signaling endosomes revealed that 314 
they contain many proteins, notably receptors, which play key roles in infection and spread of 315 
many neurotropic viruses (Debaisieux et al., 2016). Such knowledge may now provide new 316 
leads towards the identification of the cellular receptor for BDV, thereby contributing to a 317 
better understanding of BDV neuropathogenesis. 318 
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 319 
Experimental procedures 320 
 321 
Ethics statement. Animal handling and care for the preparation of primary neuronal cultures 322 
were performed in agreement with the European Union Council Directive 86/609/EEC and 323 
experiments were done following the French national chart for ethics of animal experiments 324 
(articles R 214- 87 to 90 of the “Code rural”). Our protocol received approval from the local 325 
committee on the ethics of animal experiments (permit number: 04-U1043-DG-06). Rats were 326 
deeply anesthetized with CO2 before euthanasia. 327 
 328 
Primary neuronal cultures and virus infection. Before seeding, supports were coated with 329 
500 µg/ml poly-ornithine (Sigma), followed by 5 µg/ml laminin (Roche). Primary cortical 330 
neurons were prepared from Sprague-Dawley rat embryos at gestational day 17 by the papain 331 
dissociation method as described previously (Bonnaud et al., 2015). Hippocampal neurons 332 
were prepared from newborn Sprague-Dawley rats as described (Prat et al., 2009). Neurons 333 
were maintained in Neurobasal medium (Invitrogen) supplemented with 100 µg/ml 334 
penicillin/streptomycin, 2 mM glutamine, 2 % B-27 supplement (Invitrogen) and 1 % fetal 335 
calf serum for hippocampal neurons. Neuronal cultures contained more than 90 % neurons, as 336 
assessed by staining with the neuron-specific marker ß-III tubulin (data not shown). 337 
Neurons were infected one day after plating with cell-free BDV. Cell-released virus 338 
stocks were prepared as described using Vero cells persistently infected by wild-type BDV 339 
(Giessen strain He/80) (Prat et al., 2009). Efficient BDV infection of neurons was verified by 340 
indirect immunofluorescence for each experiment. 341 
 342 
Labeling of axonal endosomes with HCT. To visualize axonal endosomes by confocal 343 
microscopy, hippocampal neurons were incubated with the binding fragment of TeNT (HCT) 344 
that was coupled with Alexa Fluor 555 dye (HCT-555), as described previously (Lalli et al., 345 
2002). Incubation was performed with 10 nM HCT-555 during 1 h at 37 °C in Neurobasal 346 
medium. To eliminate the excess of non-internalized toxin that could remain bound to cell 347 
surface receptors, one acid wash was then performed during 1 min on ice with a solution 348 
containing 100 mM citric acid and 142 mM NaCl (pH = 2), followed by two washes in PBS 349 
(Invitrogen). 350 
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 To perform flow cytometry analysis and sorting, cortical neurons were incubated with 351 
HCT coupled with Alexa Fluor 647 dye (HCT-647). Incubation was performed in Neurobasal 352 
medium containing 20 nM HCT-647, during 3 h at 37°C, followed by a 10 min incubation on 353 
ice. One acid wash was then, followed by two washes with Hank’s Buffered Salt Solution 354 
(HBSS, Invitrogen) supplemented with protease inhibitors. 355 
 356 
Indirect immunofluorescence analysis. Neurons were fixed with 2 % paraformaldehyde at 357 
room temperature for 10 min then with 4 % paraformaldehyde for 10 min. They were then 358 
washed three times with PBS and permeabilized with PBS containing 0.1 % Triton-X100 359 
during 4 min. After two washes with PBS, non-specific antigenic binding sites were blocked 360 
with 2.5 % normal goat serum (Invitrogen) during at least 1 h. Rabbit antisera recognizing 361 
BDV N or P proteins (Bonnaud et al., 2015) were diluted in PBS containing 2.5 % normal 362 
goat serum and incubated 1 h at room temperature. After three washes with PBS (containing 363 
0.1 % Triton-X100 in the first one), neurons were incubated with secondary goat anti rabbit 364 
antibody coupled to Alexa Fluor 488 during 1 h at room temperature. After three washes, 365 
coverslips were mounted onto microscope slides using Vectashield mounting medium (Vector 366 
laboratories) containing DAPI. Images were acquired on a LSM 710 confocal microscope 367 
(Zeiss) using fixed acquisition parameters and a 63x objective. Image J software was used for 368 
colocalization analyses.  369 
 370 
Preparation of cell extracts. For whole cell extract preparation, neurons were washed twice 371 
with PBS, scrapped and centrifuged for 5 min at 170 x g at 4 °C. Cell pellets were suspended 372 
in lysis solution containing 500 mM Tris-HCl pH 8, 150 mM NaCl, 0.1 % SDS, 1 % Nonidet 373 
P-40, 0.5 % sodium deoxycholate, 1 mM sodium orthovanadate and protease inhibitors 374 
(Complete mini, Roche), an incubated for 30 min at 4 °C. Lysates were then centrifuged at 375 
16000 x g for 20 min at 4 °C to eliminate cellular debris. 376 
 To preserve endosome integrity before immunoprecipitation, a gentle cell lysis was 377 
performed as follows. After two washes with HBSS containing protease inhibitors, neurons 378 
were scrapped and centrifuged for 5 min at 170 x g and 4 °C. Cell pellets were resuspended in 379 
Breaking Buffer (BB) containing 10 mM Hepes pH 7.2, 0.25 M sucrose, 1 mM EDTA, 1 mM 380 
magnesium acetate and protease inhibitors. Gentle lysis was achieved by 15 passages through 381 
a Cell cracker (18 µm clearance, EMBL Technology Transfer, GmbH). Homogenates were 382 
clarified by centrifugation at 690 x g during 15 min at 4 °C and kept at -80 °C for further 383 
analyses. 384 
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 To perform flow cytometry-based sorting, the following lysis buffer was used: 25 mM 385 
MES (2-(N-morpholino)-ethanosulfonic acid), 150 mM NaCl, 5 mM EDTA and protease 386 
inhibitors at pH 6.5 (Chasan et al., 2013). 387 
 388 
Immunoprecipitation experiments. Protein concentrations of the extracts were determined 389 
using a Bradford assay. Then 250 µg were used for all experiments, diluted in a final volume 390 
of 500 µl of BB. Lysates were pre-cleared during 30 min at 4°C using 50 µl µMACS protein 391 
G microbeads (Miltenyi Biotec). In parallel, 2 µg of goat anti pan-Trk antibodies (Santa-Cruz 392 
Biotechnologies) were coupled with 50 µl µMACS protein G microbeads (Myltenyi Biotec), 393 
then washed with BB and passed on a magnetic column (µ Columns, Myltenyi Biotec). After 394 
removal from the magnetic field, the precleared lysates were mixed with the coupled 395 
microbeads and incubated for 2 h at 4°C. After four washes on the magnetic column, elution 396 
of immunoprecipitates was performed by boiling with 60 µl of Laemmli buffer. 397 
 398 
Flow cytometry analysis and sorting. HcT-647-labeled neuronal extracts obtained after 399 
gentle lysis were analyzed and sorted by flow cytometry using a FACSARIA II SORP (BD 400 
Biosciences) equipped with DIVA software, using a protocol adapted from (Chasan et al., 401 
2013). Calibration was performed with size standard latex microbeads of 0.1, 0.5, 1 and 3 µm 402 
and 0.5, 0.9 and 3 µm FITC microbeads (Biocytex) and the fluid sheath running through the 403 
cytometer was filtered before use. Samples were analyzed at a speed of 500 to 1,000 404 
events/sec. A minimum of 10,000 events was collected for analysis. Data were analyzed using 405 
the FlowJo software (Tree Star). 406 
 407 
Western blotting. Western blots were performed as previously described (Prat et al., 2009), 408 
by using the following primary antibodies: rabbit sera anti BDV N, P, M and G (kindly 409 
provided by Martin Schwemmle for BDV M and Keizo Tomonaga for BDV G antibodies), 410 
rabbit anti Trk B antibody (Santa-Cruz Biotechnology), anti Rab7 antibody (Cell Signaling 411 
Technology), anti calnexin antibody (Enzo Life Sciences), anti GM-130 antibody (BD 412 
Biosciences) and mouse monoclonal anti ERGIC antibody (Sigma Aldrich). The secondary 413 
antibodies used were anti-rabbit and anti-mouse antibodies coupled to 680 nm and 770 nm 414 
infrared dyes (Biotium).  Laser scanning of blots and analyses were performed using the 415 
Odyssey Infrared Imaging System (Li-Cor).  416 
 417 
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Detection of BDV genomic RNA by reverse-transcription and PCR. Total RNAs were 418 
extracted from input or sorted fractions using the RNeasy micro kit (Qiagen), following the 419 
manufacter’s instructions. RNAs were reverse-transcribed using SuperScript III Reverse 420 
Transcriptase (Life Technologies) with a primer specific for genomic viral RNA (primer 421 
sequence: 5'GACACTACGACGGGAACGAT3'). The resulting cDNAs were then submitted 422 
to PCR analysis using BDV-specific primers (forward primer: 423 
5'CGGTAGACCAGCTCCTGAAG3', reverse primer: 5'GAGGTCCACCTTCTCCATCA3'), 424 
using Phusion DNA polymerase (Fermentas) and the following cycles: 3 min at 98 °C, then 425 
30 cycles with 10 sec at 98 °C, 10 sec at 55 °C, 15 sec at 72 °C, and a final incubation of 5 426 
min at 72 °C. 427 
 428 
Acknowledgments 429 
We thank the staff of the different facilities of our research center (Sophie Allart and 430 
Astrid Canivet at the cellular imaging facility and Fatima L’Faqihi-Olive and Valérie Duplan-431 
Eche at the flow cytometry platform) for excellent technical assistance that was instrumental 432 
for the proper realization of this project. We thank Arnaud Justin for technical assistance. We 433 
are grateful to Roland Liblau and Abdelhadi Saoudi for critical reading of the manuscript and 434 
insightful comments. 435 
This work was supported by grants from ANR (ANR-10-Blanc-1322, to DGD), the 436 
Fondation pour la Recherche Médicale (Equipe FRM 2009, to DGD), and institutional grants 437 
from INSERM and CNRS (to DGD). This work is part of the Ph.D. thesis work of CMC, who 438 
was supported by a doctoral fellowship from the Ministère de l’Enseignement Supérieur et de 439 
la Recherche. The funders had no role in study design, data collection and analysis, decision 440 
to publish, or preparation of the manuscript. 441 
 442 
Competing Interests 443 
The authors have declared that no competing interests exist. 444 
 445 
Author Contributions 446 
Conceived and designed the experiments: CMC, SD, GS, DGD, CEM. Performed the 447 
experiments: CMC, SD, CF, AT, CEM. Analyzed the data: CMC, DGD, CEM. Wrote the 448 
paper: DGD, CEM. 449 
 450 
Page 14 of 23Cellular Microbiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 15 
References  451 
Ascano, M., Richmond, A., Borden, P. and Kuruvilla, R. (2009). Axonal targeting of Trk 452 
receptors via transcytosis regulates sensitivity to neurotrophin responses. J Neurosci 453 
29, 11674-11685. 454 
Bajramovic, J.J., Munter, S., Syan, S., Nehrbass, U., Brahic, M. and Gonzalez-Dunia, D. 455 
(2003). Borna disease virus glycoprotein is required for viral dissemination in 456 
neurons. J Virol 77, 12222-12231. 457 
Bohnert, S. and Schiavo, G. (2005). Tetanus toxin is transported in a novel neuronal 458 
compartment characterized by a specialized pH regulation. J Biol Chem 280, 42336-459 
42344. 460 
Bonnaud, E.M., Szelechowski, M., Betourne, A., Foret, C., Thouard, A., Gonzalez-Dunia, D. 461 
and Malnou, C.E. (2015). Borna disease virus phosphoprotein modulates epigenetic 462 
signaling in neurons to control viral replication. J Virol 89, 5996-6008. 463 
Bucci, C., Alifano, P. and Cogli, L. (2014). The role of rab proteins in neuronal cells and in 464 
the trafficking of neurotrophin receptors. Membranes (Basel) 4, 642-677. 465 
Charlier, C.M., Wu, Y.J., Allart, S., Malnou, C.E., Schwemmle, M. and Gonzalez-Dunia, D. 466 
(2013). Analysis of borna disease virus trafficking in live infected cells by using a 467 
virus encoding a tetracysteine-tagged p protein. J Virol 87, 12339-12348. 468 
Chasan, A.I., Beyer, M., Kurts, C. and Burgdorf, S. (2013). Isolation of a specialized, antigen-469 
loaded early endosomal subpopulation by flow cytometry. Methods Mol Biol 960, 470 
379-388. 471 
Chavrier, P., Parton, R.G., Hauri, H.P., Simons, K. and Zerial, M. (1990). Localization of low 472 
molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 473 
62, 317-329. 474 
Clemente, R. and de la Torre, J.C. (2007). Cell-to-cell spread of Borna disease virus proceeds 475 
in the absence of the virus primary receptor and furin-mediated processing of the virus 476 
surface glycoprotein. J Virol 81, 5968-5977. 477 
Clemente, R. and de la Torre, J.C. (2009). Cell entry of Borna disease virus follows a clathrin-478 
mediated endocytosis pathway that requires Rab5 and microtubules. J Virol 83, 479 
10406-10416. 480 
Daito, T., Fujino, K., Honda, T., Matsumoto, Y., Watanabe, Y. and Tomonaga, K. (2011a). A 481 
novel borna disease virus vector system that stably expresses foreign proteins from an 482 
intercistronic noncoding region. J Virol 85, 12170-12178. 483 
Daito, T., Fujino, K., Watanabe, Y., Ikuta, K. and Tomonaga, K. (2011b). Analysis of 484 
intracellular distribution of Borna disease virus glycoprotein fused with fluorescent 485 
markers in living cells. J Vet Med Sci 73, 1243-1247. 486 
de la Torre, J.C. (1994). Molecular biology of borna disease virus: prototype of a new group 487 
of animal viruses. J Virol 68, 7669-7675. 488 
de la Torre, J.C. (2002). Molecular biology of Borna disease virus and persistence. Front 489 
Biosci 7, d569-579. 490 
Debaisieux, S., Encheva, V., Chakravarty, P., Snijders, A.P. and Schiavo, G. (2016). Analysis 491 
of Signaling Endosome Composition and Dynamics Using SILAC in Embryonic Stem 492 
Cell-Derived Neurons. Mol Cell Proteomics 15, 542-557. 493 
Deinhardt, K., Salinas, S., Verastegui, C., Watson, R., Worth, D., Hanrahan, S., et al. (2006). 494 
Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport 495 
pathway. Neuron 52, 293-305. 496 
Diefenbach, R.J., Miranda-Saksena, M., Douglas, M.W. and Cunningham, A.L. (2008). 497 
Transport and egress of herpes simplex virus in neurons. Rev Med Virol 18, 35-51. 498 
Page 15 of 23 Cellular Microbiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 16 
Gonzalez-Dunia, D., Cubitt, B. and de la Torre, J.C. (1998). Mechanism of Borna disease 499 
virus entry into cells. J Virol 72, 783-788. 500 
Gonzalez-Dunia, D., Volmer, R., Mayer, D. and Schwemmle, M. (2005). Borna disease virus 501 
interference with neuronal plasticity. Virus Res 111, 224-234. 502 
Lalli, G., Bohnert, S., Deinhardt, K., Verastegui, C. and Schiavo, G. (2003). The journey of 503 
tetanus and botulinum neurotoxins in neurons. Trends Microbiol 11, 431-437. 504 
Lalli, G., Herreros, J., Osborne, S.L., Montecucco, C., Rossetto, O. and Schiavo, G. (1999). 505 
Functional characterisation of tetanus and botulinum neurotoxins binding domains. J 506 
Cell Sci 112 ( Pt 16), 2715-2724. 507 
Lalli, G. and Schiavo, G. (2002). Analysis of retrograde transport in motor neurons reveals 508 
common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. J 509 
Cell Biol 156, 233-239. 510 
Lennartz, F., Bayer, K., Czerwonka, N., Lu, Y., Kehr, K., Hirz, M., et al. (2016). Surface 511 
glycoprotein of Borna disease virus mediates virus spread from cell to cell. Cell 512 
Microbiol 18, 340-354. 513 
Lipkin, W.I., Briese, T. and Hornig, M. (2011). Borna disease virus - fact and fantasy. Virus 514 
Res 162, 162-172. 515 
Marra, P., Maffucci, T., Daniele, T., Tullio, G.D., Ikehara, Y., Chan, E.K., et al. (2001). The 516 
GM130 and GRASP65 Golgi proteins cycle through and define a subdomain of the 517 
intermediate compartment. Nat Cell Biol 3, 1101-1113. 518 
Mitchell, D.J., Blasier, K.R., Jeffery, E.D., Ross, M.W., Pullikuth, A.K., Suo, D., et al. 519 
(2012). Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain 520 
phosphorylation and recruits cytoplasmic dynein to signaling endosomes for 521 
retrograde axonal transport. J Neurosci 32, 15495-15510. 522 
Prat, C.M., Schmid, S., Farrugia, F., Cenac, N., Le Masson, G., Schwemmle, M. and 523 
Gonzalez-Dunia, D. (2009). Mutation of the protein kinase C site in borna disease 524 
virus phosphoprotein abrogates viral interference with neuronal signaling and restores 525 
normal synaptic activity. PLoS Pathog 5, e1000425. 526 
Salinas, S., Bilsland, L.G., Henaff, D., Weston, A.E., Keriel, A., Schiavo, G. and Kremer, E.J. 527 
(2009). CAR-associated vesicular transport of an adenovirus in motor neuron axons. 528 
PLoS Pathog 5, e1000442. 529 
Salinas, S., Schiavo, G. and Kremer, E.J. (2010). A hitchhiker's guide to the nervous system: 530 
the complex journey of viruses and toxins. Nat Rev Microbiol 8, 645-655. 531 
Salomon, I., Janssen, H. and Neefjes, J. (2010). Mechanical forces used for cell fractionation 532 
can create hybrid membrane vesicles. Int J Biol Sci 6, 649-654. 533 
Schweizer, A., Fransen, J.A., Bachi, T., Ginsel, L. and Hauri, H.P. (1988). Identification, by a 534 
monoclonal antibody, of a 53-kD protein associated with a tubulo-vesicular 535 
compartment at the cis-side of the Golgi apparatus. J Cell Biol 107, 1643-1653. 536 
Taylor, M.P. and Enquist, L.W. (2015). Axonal spread of neuroinvasive viral infections. 537 
Trends Microbiol 23, 283-288. 538 
Wada, I., Rindress, D., Cameron, P.H., Ou, W.J., Doherty, J.J., 2nd, Louvard, D., et al. 539 
(1991). SSR alpha and associated calnexin are major calcium binding proteins of the 540 
endoplasmic reticulum membrane. J Biol Chem 266, 19599-19610. 541 
Wu, Y.J., Schulz, H., Lin, C.C., Saar, K., Patone, G., Fischer, H., et al. (2013). Borna disease 542 
virus-induced neuronal degeneration dependent on host genetic background and 543 
prevented by soluble factors. Proc Natl Acad Sci U S A 110, 1899-1904. 544 
Zhou, B., Cai, Q., Xie, Y. and Sheng, Z.H. (2012). Snapin recruits dynein to BDNF-TrkB 545 
signaling endosomes for retrograde axonal transport and is essential for dendrite 546 
growth of cortical neurons. Cell Rep 2, 42-51. 547 
 548 
Page 16 of 23Cellular Microbiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 17 
 549 
 550 
Figure legends 551 
 552 
Figure 1. BDV N and P colocalize with the binding fragment of tetanus neurotoxin 553 
(HCT), a marker for axonal endosomes. Analysis of the colocalization between BDV N (A) 554 
or P (B) and HCT by confocal microscopy. Upper panels: Hippocampal neurons were infected 555 
by BDV during 10 days before incubation with HCT-555. BDV N (A) or P (B) proteins were 556 
detected by immunofluorescence (green signal) and the colocalization with HCT-555 (red 557 
signal) was analyzed by confocal microscopy. Scale bar = 5 µm. Lower panels: Fluorescence 558 
intensity profiles of the green and red signals measured along the white arrow pictured on the 559 
upper corresponding image. (C) Quantification of the colocalization between BDV N or P 560 
with HCT in axons. The histogram corresponds to the percentage of vesicles showing a 561 
colocalization between BDV proteins and HCT-555. Data are expressed as means ± s. e. m. 562 
for: BDV N: 3 independent experiments, 23 fields and 210 BDV-containing vesicles; BDV P: 563 
2 independent experiments, 21 fields and 171 BDV-containing vesicles. 564 
 565 
Figure 2. Graphical overview of the methodologies employed to analyze the content of 566 
axonal endosomes. Method 1: Primary cortical neurons were infected or not with BDV, then 567 
submitted to either whole cell lysis, or a gentle lysis protocol designed to preserve the 568 
integrity of axonal endosomes. Extracts were then used in immunoprecipitation experiments 569 
using an anti-panTrk antibody, before western-blot analysis of the content of the 570 
immunoprecipitated fraction. Method 2: Primary cortical neurons were infected or not with 571 
BDV and incubated with HCT-647. After gentle cell lysis, flow cytometry-based sorting of 572 
axonal endosomes was performed before analyzing the content of the positive-sorted fractions. 573 
 574 
Figure 3. BDV proteins are found in immunoprecipitated axonal endosomes. Western 575 
blot analysis of the content of pan-Trk immunoprecipitated fractions. (A) Cortical neurons 576 
were infected (BDV) or not (NI) by BDV, then subjected to whole cell lysis before anti pan-577 
Trk immunoprecipitation. Whole cell lysates (Input) or immunoprecipitated fractions (IP) 578 
were loaded onto SDS-PAGE before western blot using antibodies indicated on the left. Anti 579 
BDV G serum can detect the two isoforms of the protein, at 84 and 43 kDa. The star indicates 580 
a non-specific band, the arrowhead indicates the specific 84 kDa BDV G protein. (B) Cortical 581 
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neurons were infected (BDV) or not (NI) by BDV, then subjected to gentle cell lysis, 582 
preserving the integrity of axonal endosomes, before anti pan-Trk immunoprecipitation. Cell 583 
homogenates (Input) or immunoprecipitated fraction (IP) were loaded onto SDS-PAGE 584 
before western blot using the indicated antibodies. (C) Western blot analysis was performed 585 
on the same samples as (B) with the indicated antibodies, to control the purity of the axonal 586 
endosome preparations. Data shown are representative of one experiment out of five, that all 587 
provided similar results. 588 
 589 
Figure 4. Flow cytometry analysis of fluorescent axonal endosomes. (A) Analysis of 590 
fluorescent vesicles obtained from non-infected neurons that were incubated with HCT-647. 591 
Left panel: Crude fraction obtained after gentle lysis of neurons (acquired with instrument 592 
settings identical as those used for size standard beads) were size-gated into three populations 593 
designated P1 to P3. Right panels: Individual analyses of P1 to P3 populations, based on 594 
fluorescence intensity and counts. Numbers indicate the frequency of Alexa 647-positive 595 
events that were gated (right side of the graph) before sorting to obtain F1 and F2 fractions 596 
(no sorting was done on P3 population). Data shown are from one representative experiment 597 
out of four. (B) The same analysis was done on vesicles isolated from non-infected neurons 598 
that were not incubated with HCT-647. In this case, no sorting was performed. 599 
 600 
Figure 5. BDV proteins and genome are found in sorted axonal endosomes. Cortical 601 
neurons were infected (BDV) or not (NI) by BDV and subjected to gentle cell lysis before 602 
flow cytometry sorting and analysis. (A) Cell lysate before sorting (Input) or F1 sorted 603 
fraction (F1) were loaded onto SDS-PAGE before western blot using the indicated antibodies. 604 
The star indicates a non-specific band detected with the anti BDV M antibody. (B) Western 605 
blot analysis was performed on the same samples as in (A) with the indicated antibodies, to 606 
control the purity of axonal endosomes after sorting. Data shown are representative of one 607 
experiment out of two to four experiments. (C) Analysis of the presence of viral genome into 608 
sorted axonal endosomes by RT-PCR. Total RNAs were extracted from Input or F1 sorted 609 
fractions, reverse transcribed and analyzed by PCR using primers specific for viral genome. 610 
Amplified cDNAs were then loaded onto 1 % agarose gel. Mock: reverse-transcriptase was 611 
not added in the RT-PCR. MW: molecular weight ladder. 612 
 613 
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